Skip to main content

  • Mitral TEER with MitraClip Still Shows Lower HF Hospitalization, All-Cause Death vs. Medical Therapy Alone at 5 Years in Functional MR – COAPT

    High event rate shows need for more advances in treating this high-risk population, lead investigator says

    Transcatheter edge-to-edge repair (TEER) of the mitral valve plus maximally tolerated guideline-directed medical therapy (GDMT) in patients with severe functional mitral regurgitation (MR) continued to show a significantly lower rate of heart failure hospitalization or all-cause mortality than GDMT alone through 5-year follow-up, new results from the COAPT trial show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details